For the millions of people living with genetic diseases like muscular dystrophy and inherited liver disorders, one of the ...
Most of the developments that end up reshaping daily life don't announce themselves with fanfare. They start in laboratories, ...
Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...
In the May + June 2026 issue, we investigate our new AI overlords and the world they are striving to create, whether we like ...
Scientists have found the strongest evidence to date that a condition known as Barrett's esophagus is the starting point for ...
Northwestern Medicine scientists have uncovered an unexpected role for a well-known cancer-related protein, revealing a new ...
Dozens of new discoveries reveal that defenses evolved by bacteria and viruses billions of years ago still define our own ...
Researchers at NYU Langone Health propose a model that could explain how cancer cells adapt to environmental stress, an approach that may lead to new ...
Pharmaceutical Technology on MSN

FDA shares guide on genome editing best practices

This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating genome editing.
Researchers with Diakonos Oncology are working to extend the lives of other patients diagnosed with other forms of cancer.
A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.